Fig. 5

A 64-year-old female patient with history of bilateral ovarian cancer, submitted for TAH BSO, followed by CTH and hormonal treatment, presented with recently elevated CA 15.3 and CA 125 serum levels. (a) Whole body PET MIP image revealed multiple metabolically active scattered abdominal and pelvic lesions. CECT (b, d and f) and corresponding fused PET/CT (c, e and g) images revealed multiple variable-sized peritoneal discrete soft tissue nodules unevenly distributed in the peritoneal cavity (orange arrows), the largest and most active is seen at the left hypochondrial region (achieving 24.9 SUVmax). Other hypermetabolic metastatic hepatic deposit (red arrow) and left external iliac LNs (green arrows) are noted, achieving up to 9 and 14.1 SUVmax, respectively